Literature DB >> 25351757

Relationship between silent atrial fibrillation and the maximum heart rate in the 24-hour Holter: cross-sectional study.

Marcelo Lapa Kruse1, José Cláudio Lupi Kruse1, Tiago Luiz Luz Leiria1, Leonardo Martins Pires1, Caroline Saltz Gensas1, Daniel Garcia Gomes1, Douglas Boris1, Augusto Mantovani1, Gustavo Glotz de Lima1.   

Abstract

CONTEXT AND
OBJECTIVE: Occurrences of asymptomatic atrial fibrillation (AF) are common. It is important to identify AF because it increases morbidity and mortality. 24-hour Holter has been used to detect paroxysmal AF (PAF). The objective of this study was to investigate the relationship between occurrence of PAF in 24-hour Holter and the symptoms of the population studied. DESIGN AND
SETTING: Cross-sectional study conducted at a cardiology hospital.
METHODS: 11,321 consecutive 24-hour Holter tests performed at a referral service were analyzed. Patients with pacemakers or with AF throughout the recording were excluded.
RESULTS: There were 75 tests (0.67%) with PAF. The mean age was 67 ± 13 years and 45% were female. The heart rate (HR) over the 24 hours was a minimum of 45 ± 8 bpm, mean of 74 ± 17 bpm and maximum of 151 ± 32 bpm. Among the tests showing PAF, only 26% had symptoms. The only factor tested that showed a correlation with symptomatic AF was maximum HR (165 ± 34 versus 147 ± 30 bpm) (P = 0.03). Use of beta blockers had a protective effect against occurrence of PAF symptoms (odds ratio: 0.24, P = 0.031).
CONCLUSIONS: PAF is a rare event in 24-hour Holter. The maximum HR during the 24 hours was the only factor correlated with symptomatic AF, and use of beta blockers had a protective effect against AF symptom occurrence.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25351757

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  1 in total

1.  Atrial fibrillation among Russian men and women aged 55 years and older: prevalence, mortality, and associations with biomarkers in a population-based study.

Authors:  Maria A Shkolnikova; Dmitri A Jdanov; Rukizhat A Ildarova; Natalia V Shcherbakova; Ekaterina B Polyakova; Evgeny N Mikhaylov; Svetlana A Shalnova; Vladimir M Shkolnikov
Journal:  J Geriatr Cardiol       Date:  2020-02       Impact factor: 3.327

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.